At Week 4 ( Study 2 ) , there were no meaningful changes from baseline in the mean central retinal thickness ( 37.9 m ) or best-corrected visual acuity ( 0.1 letters ) ( primary endpoint ) , retinal morphology , choroidal neovascularization size , or total lesion size .